Table Info

Taxonomic rank	Classification
Order	Nidovirales
Suborder	Cornidovirineae
Family	Coronaviridae
Subfamily	Orthocoronavirinae
Genera	Betacoronavirus
Subgenera	Sarbecovirus
Specie	SARS-CoV-2

Declarations

Acknowledgments

The author thanks Luis Bermudez Humaran for his help in the preparation of the figures.

Author contributions

The author contributed solely to the work.

Conflicts of interest

The author declares that he has no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Morse SS, Mazet JA, Woolhouse M, Parrish CR, Carroll D, Karesh WB, et al. Prediction and prevention of the next pandemic zoonosis. Lancet. 2012;380:1956–65. [DOI] [PubMed] [PMC]

Trovato M, Sartorius R, D’pice L, Manco R, De Berardinis P. Viral emerging diseases: challenges in developing vaccination strategies. Front Immunol. 2020;11:2130. [DOI] [PubMed] [PMC]

Tomalka JA, Suthar MS, Deeks SG, Sekaly RP. Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses. Nat Immunol. 2022;23:360–70. [DOI] [PubMed]

Gasteiger G, D’Oaldo A, Schubert DA, Weber A, Bruscia EM, Hartl D. Cellular inate immunity: an old game with new players. J Innate Immun. 2017;9:111–25. [DOI] [PubMed] [PMC]

Netea MG, Balkwill F, Chonchol M, Cominelli F, Donath MY, Giamarellos-Bourboulis EJ, et al. A guiding map for inflammation. Nat Immunol. 2017;18:826–31. [DOI] [PubMed] [PMC]

Jentho E, Weis S. DAMPs and innate immune training. Front Immunol. 2021;12:699563. [DOI] [PubMed] [PMC]

Gardiner CM, Mills KH. The cells that mediate innate immune memory and their functional significance in inflammatory and infectious diseases. Semin Immunol. 2016;28:343–50. [DOI] [PubMed]

Netea MG, Domínguez-Andrés J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20:375–88. [DOI] [PubMed] [PMC]

Cortes-Perez NG, de Moreno de LeBlanc A, Gomez-Gutierrez JG, LeBlanc JG, Bermudez-Humaran LG. Probiotics and trained immunity. Biomolecules. 2021;11:1402. [DOI] [PubMed] [PMC]

10.

Anderson HL, Brodsky IE, Mangalmurti NS. The evolving erythrocyte: red blood cells as modulators of innate immunity. J Immunol. 2018;201:1343–51. [DOI] [PubMed] [PMC]

11.

Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe. 2011;9:355–61. [DOI] [PubMed]

12.

Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, et al. Trained immunity: a program of innate immune memory in health and disease. Science. 2016;352:aaf1098. [DOI] [PubMed] [PMC]

13.

Netea MG, van der Meer JW. Trained immunity: an ancient way of remembering. Cell Host Microbe. 2017;21:297–300. [DOI] [PubMed]

14.

Fanucchi S, Domínguez-Andrés J, Joosten LAB, Netea MG, Mhlanga MM. The intersection of epigenetics and metabolism in trained immunity. Immunity. 2021;54:32–43. [DOI] [PubMed]

15.

Zhou Z, Qiu Y, Ge X. The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order. Anim Dis. 2021;1:5. [DOI] [PubMed] [PMC]

16.

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–44. [DOI] [PubMed] [PMC]

17.

V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19:155–70. [DOI] [PubMed] [PMC]

18.

Cavanagh D. The coronavirus surface glycoprotein. In: Siddell SG, editor. The coronaviridae. Boston, MA: Springer US; 1995. pp. 73–113. [DOI]

19.

de Haan CA, Vennema H, Rottier PJ. Assembly of the coronavirus envelope: homotypic interactions between the M proteins. J Virol. 2000;74:4967–78. [DOI] [PubMed] [PMC]

20.

WHO coronavirus (COVID-19) dashboard [Internet]. Switzerland: World Health Organization; [cited 2022 Apr 7]. Available from: https://covid19.who.int/

21.

Weekly epidemiological update on COVID-19 - 5 April 2022 [Internet]. Switzerland: World Health Organization; [cited 2022 Apr 7]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---5-april-2022

22.

Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol. 2022;23:165–76. [DOI] [PubMed] [PMC]

23.

Scudellari M. How the coronavirus infects cells - and why Delta is so dangerous. Nature. 2021;595:640–4. [DOI] [PubMed]

24.

Mandala VS, McKay MJ, Shcherbakov AA, Dregni AJ, Kolocouris A, Hong M. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat Struct Mol Biol. 2020;27:1202–8. [DOI] [PubMed] [PMC]

25.

Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Struct Mol Biol. 2022;23:3–20. [DOI] [PubMed] [PMC]

26.

Watanabe Y, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. 2020;369:330–3. [DOI] [PubMed] [PMC]

27.

Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020;78:779–84.e5. [DOI] [PubMed] [PMC]

28.

Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020;117:11727–34. [DOI] [PubMed] [PMC]

29.

Lavie M, Dubuisson J, Belouzard S. SARS-CoV-2 spike furin cleavage site and S2’ basic residues modulate the entry process in a host cell-dependent manner. J Virol. 2022;96:e0047422. [DOI] [PubMed] [PMC]

30.

Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care. 2020;24:422. [DOI] [PubMed] [PMC]

31.

Zheng M. ACE2 and COVID-19 susceptibility and severity. Aging Dis. 2022;13:360–72. [DOI] [PubMed] [PMC]

32.

Acevedo OA, Berrios RV, Rodriguez-Guilarte L, Lillo-Dapremont B, Kalergis AM. Molecular and cellular mechanisms modulating trained immunity by various cell types in response to pathogen encounter. Front Immunol. 2021;12:745332. [DOI] [PubMed] [PMC]

33.

Rose M, Duhamel M, Rodet F, Salzet M. The role of proprotein convertases in the regulation of the function of immune cells in the oncoimmune response. Front Immunol. 2021;12:667850. [DOI] [PubMed] [PMC]

34.

You M, Chen L, Zhang D, Zhao P, Chen Z, Qin EQ, et al. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19. Nat Cell Biol. 2021;23:620–30. [DOI] [PubMed] [PMC]

35.

Netea MG, Li Y. Immune memory in individuals with COVID-19. Nat Cell Biol. 2021;23:582–4. [DOI] [PubMed]

36.

Lee JH, Koepke L, Kirchhoff F, Sparrer KMJ. Interferon antagonists encoded by SARS-CoV-2 at a glance. Med Microbiol Immunol. 2022;[Epub ahead of print]. [DOI] [PubMed] [PMC]

37.

Kasuga Y, Zhu B, Jang KJ, Yoo JS. Innate immune sensing of coronavirus and viral evasion strategies. Exp Mol Med. 2021;53:723–36. [DOI] [PubMed] [PMC]

38.

Kikkert M. Innate immune evasion by human respiratory RNA viruses. J Innate Immun. 2020;12:4–20. [DOI] [PubMed] [PMC]

39.

Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, Vogel P, et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22:829–38. [DOI] [PubMed] [PMC]

40.

Sariol A, Perlman S. SARS-CoV-2 takes its toll. Nat Immunol. 2021;22:801–2. [DOI] [PubMed] [PMC]

41.

Szabo MP, Iba M, Nath A, Masliah E, Kim C. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS. Exp Mol Med. 2022;54:447–54. [DOI] [PubMed] [PMC]

42.

Choudhury A, Mukherjee S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol. 2020;92:2105–13. [DOI] [PubMed] [PMC]

43.

Kayesh MEH, Kohara M, Tsukiyama-Kohara K. An overview of recent insights into the response of TLR to SARS-CoV-2 infection and the potential of TLR agonists as SARS-CoV-2 vaccine adjuvants. Viruses. 2021;13:2302. [DOI] [PubMed] [PMC]

44.

Aboudounya MM, Heads RJ. COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediators Inflamm. 2021;2021:8874339. [DOI] [PubMed] [PMC]

45.

Mabrey FL, Morrell ED, Wurfel MM. TLRs in COVID-19: how they drive immunopathology and the rationale for modulation. Innate Immun. 2021;27:503–13. [DOI] [PubMed] [PMC]

46.

Patra R, Chandra Das N, Mukherjee S. Targeting human TLRs to combat COVID-19: a solution? J Med Virol. 2021;93:615–7. [DOI] [PubMed] [PMC]

47.

Zhao Y, Kuang M, Li J, Zhu L, Jia Z, Guo X, et al. SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 2021;31:818–20. Erratum in: Cell Res. 2021;31:825. [DOI] [PubMed] [PMC]

48.

Petruk G, Puthia M, Petrlova J, Samsudin F, Strömdahl AC, Cerps S, et al. SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity. J Mol Cell Biol. 2020;12:916–32. [DOI] [PubMed] [PMC]

49.

Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;5:283. [DOI] [PubMed] [PMC]

50.

Geng JJ, Tang J, Yang XM, Chen R, Zhang Y, Zhang K, et al. Targeting CD147 for T to NK lineage reprogramming and tumor therapy. EBioMedicine. 2017;20:98–108. [DOI] [PubMed] [PMC]

51.

Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631–7. [DOI] [PubMed] [PMC]

52.

Salamanna F, Maglio M, Landini MP, Fini M. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne). 2020;7:594495. [DOI] [PubMed] [PMC]

53.

Bao R, Hernandez K, Huang L, Luke JJ. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19. J Immunother Cancer. 2020;8:e001020. [DOI] [PubMed] [PMC]

54.

Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al.; HCA Lung Biological Network. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016–35.e19. [DOI] [PubMed] [PMC]

55.

Gorący A, Rosik J, Szostak B, Ustianowski Ł, Ustianowska K, Gorący J. Human cell organelles in SARS-CoV-2 infection: an up-to-date overview. Viruses. 2022;14:1092. [DOI] [PubMed] [PMC]

56.

Uhlen M, Karlsson MJ, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366:eaax9198. [DOI] [PubMed]

57.

Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci. 2022;79:187. [DOI] [PubMed] [PMC]

58.

Chen L, Ozato K. Innate immune memory in hematopoietic stem/progenitor cells: myeloid-biased differentiation and the role of interferon. Front Immunol. 2021;12:621333. [DOI] [PubMed] [PMC]

59.

Jalloh S, Olejnik J, Berrigan J, Nisa A, Suder EL, Akiyama H, et al. CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses. BioRxiv 486190 [Preprint]. 2022 [cited 2022 Mar 30]. Available from: https://www.biorxiv.org/content/10.1101/2022.03.29.486190v2

60.

Lempp FA, Soriaga LB, Montiel-Ruiz M, Benigni F, Noack J, Park YJ, et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021;598:342–7. [DOI] [PubMed]

61.

Lu Q, Liu J, Zhao S, Gomez Castro MF, Laurent-Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and tweety family member 2. Immunity. 2021;54:1304–19.e9. [DOI] [PubMed] [PMC]

62.

Onodi F, Bonnet-Madin L, Meertens L, Karpf L, Poirot J, Zhang SY, et al. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. J Exp Med. 2021;218:e20201387. [DOI] [PubMed] [PMC]

63.

van der Sluis RM, Cham LB, Gris-Oliver A, Gammelgaard KR, Pedersen JG, Idorn M, et al. TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection. EMBO J. 2022;41:e109622. [DOI] [PubMed] [PMC]

64.

Percivalle E, Sammartino JC, Cassaniti I, Arbustini E, Urtis M, Smirnova A, et al. Macrophages and monocytes: “Trojan horses” in COVID-19. Viruses. 2021;13:2178. [DOI] [PubMed] [PMC]

65.

Dalskov L, Møhlenberg M, Thyrsted J, Blay-Cadanet J, Poulsen ET, Folkersen BH, et al. SARS-CoV-2 evades immune detection in alveolar macrophages. EMBO Rep. 2020;21:e51252. [DOI] [PubMed] [PMC]

66.

Tseng CT, Perrone LA, Zhu H, Makino S, Peters CJ. Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J Immunol. 2005;174:7977–85. [DOI] [PubMed]

67.

Boumaza A, Gay L, Mezouar S, Bestion E, Diallo AB, Michel M, et al. Monocytes and macrophages, targets of severe acute respiratory syndrome coronavirus 2: the clue for coronavirus disease 2019 immunoparalysis. J Infect Dis. 2021;224:395–406. [DOI] [PubMed] [PMC]

68.

Shin D, Mukherjee R, Grewe D, Bojkova D, Baek K, Bhattacharya A, et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587:657–62. [DOI] [PubMed] [PMC]

69.

Halim TY, Steer CA, Mathä L, Gold MJ, Martinez-Gonzalez I, McNagny KM, et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity. 2014;40:425–35. [DOI] [PubMed] [PMC]

70.

Gomez-Cadena A, Spehner L, Kroemer M, Khelil MB, Bouiller K, Verdeil G, et al. Severe COVID-19 patients exhibit an ILC2 NKG2D⁺ population in their impaired ILC compartment. Cell Mol Immunol. 2021;18:484–6. [DOI] [PubMed] [PMC]

71.

Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2004;23:255–9. [DOI] [PubMed] [PMC]

72.

Björkström NK, Strunz B, Ljunggren HG. Natural killer cells in antiviral immunity. Nat Rev Immunol. 2022;22:112–23. [DOI] [PubMed] [PMC]

73.

Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F, et al. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021;600:295–301. [DOI] [PubMed]

74.

Krämer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-García R, et al.; Deutsche COVID-19 OMICS Initiative (DeCOI); Aschenbrenner AC, Schultze JL, Nattermann J. Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity. 2021;54:2650–69.e14. [DOI] [PubMed] [PMC]

75.

Leem G, Cheon S, Lee H, Choi SJ, Jeong S, Kim ES, et al. Abnormality in the NK-cell population is prolonged in severe COVID-19 patients. J Allergy Clin Immunol. 2021;148:996–1006.e18. [DOI] [PubMed] [PMC]

76.

Kim H, Byun JE, Yoon SR, Koohy H, Jung H, Choi I. SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity. Cell Immunol. 2022;371:104454. [DOI] [PubMed] [PMC]

77.

Hammer Q, Dunst J, Christ W, Picarazzi F, Wendorff M, Momayyezi P, et al.; Karolinska COVID-19 Study Group, Severe COVID-19 GWAS Group; Degenhardt F, Franke A, Spallotta F, Mori M, Michaëlsson J, Björkström NK, et al. SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells. Cell Rep. 2022;38:110503. [DOI] [PubMed] [PMC]

78.

van Erp EA, van Kampen MR, van Kasteren PB, de Wit J. Viral infection of human natural killer cells. Viruses. 2019;11:243. [DOI] [PubMed] [PMC]

79.

Hazeldine J, Lord JM. Neutrophils and COVID-19: ative participants and rational therapeutic targets. Front Immunol. 2021;12:680134. [DOI] [PubMed] [PMC]

80.

Rawat S, Vrati S, Banerjee A. Neutrophils at the crossroads of acute viral infections and severity. Mol Aspects Med. 2021;81:100996. [DOI] [PubMed] [PMC]

81.

Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217:e20201129. [DOI] [PubMed] [PMC]

82.

Moreno-Eutimio MA, López-Macías C, Pastelin-Palacios R. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microbes Infect. 2020;22:226–9. [DOI] [PubMed] [PMC]